Health Care & Life Sciences » Pharmaceuticals | Sichuan Kelun Pharmaceutical Co. Ltd.

Sichuan Kelun Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6,765
7,952
7,688
8,447
11,250
16,123
Cost of Goods Sold (COGS) incl. D&A
3,797
4,710
4,616
4,965
5,682
6,762
Gross Income
2,968
3,242
3,072
3,482
5,568
9,361
SG&A Expense
1,481
1,756
1,946
2,390
4,454
7,597
EBIT
1,454
1,426
1,036
1,088
1,039
1,700
Unusual Expense
144
139
30
72
184
143
Non Operating Income/Expense
15
18
178
12
23
204
Interest Expense
210
278
318
359
556
633
Pretax Income
1,281
1,141
675
709
1,125
1,187
Income Tax
191
164
139
92
330
66
Equity in Affiliates
2
8
6
8
16
147
Consolidated Net Income
1,091
985
542
624
811
1,267
Net Income
1,080
1,002
645
585
749
1,213
Net Income After Extraordinaries
1,080
1,002
645
585
749
1,213
Net Income Available to Common
1,080
1,002
645
585
749
1,213
EPS (Basic)
0.75
0.70
0.45
0.41
0.52
0.84
Basic Shares Outstanding
1,440
1,440
1,440
1,440
1,440
1,440
EPS (Diluted)
0.75
0.70
0.45
0.41
0.52
0.84
Diluted Shares Outstanding
1,440
1,440
1,440
1,440
1,440
1,440
EBITDA
1,786
1,933
1,611
1,743
1,844
2,689
Other Operating Expense
33
60
90
4
76
63
Non-Operating Interest Income
62
61
52
40
798
27
Minority Interest Expense
12
17
103
40
63
55

About Sichuan Kelun Pharmaceutical Co.

View Profile
Address
No. 36 West Baihua Road
Chengdu Sichuan 610071
China
Employees -
Website http://www.kelun.com
Updated 07/08/2019
Sichuan Kelun Pharmaceutical Co., Ltd. engages in manufacture and sale of pharmaceutical products. Its products include IV Solutions, lyophilized, Sterile powders for injection, Tablets, Capsules, Oral Preparations, Injectable Powder, Antipsychotic, Respiratory System, Anti-pathogenic Microorganisms, APIs and Intermediates, SVP and medical devices. It also provides dialysis solutions, APIs, pharmaceutical packaging materials, medical devices, and antibiotic intermediates.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.